Insider Transactions in Q3 2023 at Transcode Therapeutics, Inc. (RNAZ)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Robert Michael Dudley Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
98,000
+35.22%
|
$0
$0.51 P/Share
|
|
Sep 28
2023
|
Thomas A Fitzgerald Interim CEO, CFO |
BUY
Open market or private purchase
|
Direct |
49,350
+46.7%
|
$0
$0.51 P/Share
|